Search

everythinglearnresearchcommunity

for

Search:↓

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.

The new cream is safe and effective for mild to moderate atopic dermatitis.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

SIG-1451 could be a promising new treatment for atopic dermatitis.

SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.

Consider DRIF and perform skin biopsies for persistent papular rashes.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

Atopic dermatitis significantly lowers the quality of life for infants and their families.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Cats with atopic dermatitis often have severe, year-round itching and respond well to certain treatments.

Childhood atopic dermatitis does not significantly affect general cognition.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Sandalore®, a synthetic scent, reduced hair loss and improved hair growth in women with telogen effluvium.

Vitamin D is important for skin health and can help treat psoriasis, atopic dermatitis, and vitiligo.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Most hospitalized children with skin issues were boys, with allergic skin diseases like atopic dermatitis being most common, and treatments were usually topical.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

Inflammatory skin conditions are the most common in Brazilian children, with atopic dermatitis being the top issue.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Psychological stress is a major factor in the onset and severity of alopecia areata, with atopic individuals being more prone to develop it.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Type 2 cytokines IL-4 and IL-13 increase skin's vulnerability to Staphylococcus aureus, which could be important for treating atopic dermatitis.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.